Net Loss per Share

6 Months Ended

Jun. 30, 2026

The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company:


	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
Net loss	$	(17,797	)	$	(12,301	)	$	(30,989	)	$	(22,641	)
Weighted average shares of common stock used in net loss per share attributable to common stockholders, basic and diluted		156,602,158			130,350,391			151,127,942			124,015,763
Basic and diluted net loss per common share outstanding	$	(0.11	)	$	(0.09	)	$	(0.21	)	$	(0.18	)

Basic shares outstanding includes the weighted average effect of the Company’s pre-funded warrants from the date of issuance, the exercise of which requires little or no consideration for the delivery of shares of common stock. As of both June 30, 2026 and December 31, 2025, the Company had pre-funded warrants to purchase 17,248,948 shares of common stock outstanding, which were issued in the April 2022 Private Placement and the September 2022 Offering, which warrants are included in the weighted average shares of common stock used in calculating the net loss per share attributable to common stockholders, basic and diluted, for each of the three and six months ended June 30, 2026 and 2025.

The Company’s potential dilutive securities, which include stock options and warrants that are not pre-funded, have been excluded from the computation of diluted net loss per share attributable to common stockholders whenever the effect of including

them would be to reduce the net loss per share. In periods where there is a net loss, the weighted average number of shares of common stock outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The following potential shares of common stock, presented based on shares outstanding as of June 30, 2026 and 2025, respectively, were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:


	Shares as of June 30,
	2026		2025
Stock Options		11,777,190		10,239,338
Warrants		1,851,852		1,851,852
Total potential shares of common stock		13,629,042		12,091,190